Figure 4.
mtm controls endolysosome homeostasis. (A’–B’, C’, D’, E’, F’, and G’) mtm is necessary and sufficient to restrict size of acidified endolysosomes in Kc167 cells (A’–B’, D’, and F’) and primary hemocytes (C’, E’, and G’). (A’ and B’–C’) Normal early endosomes (A’; anti-Rab5) and enlarged and convoluted late endosomes (B’–C’; GFP:Rab7; green) with mtm RNAi are shown. (D’–G’) Both mtm RNAi and null alleles resulted in enlarged acidified endolysosomes (LysoTracker, red; GFP-LAMP, green) that reverted to normal size with mtm:GFP cDNA (G). (H) Area of individual Rab5, GFP:Rab7, and LysoTracker-stained organelles in Kc167 cells. (I–J’) Area of LysoTracker-positive organelles decreased in mCherry:mtm-expressing hemocytes. (K and K’) Ultrastructure of mtm RNAi Kc167 cells revealed an increase in secondary lysosomes (shaded pink) and electron-lucent membrane compartments (arrowheads). (L and L’) Examples of secondary lysosomes. (M) Secondary lysosome area shown as the percentage of cell area (means: control, 1.8%; mtm RNAi cell area, 5.0%). (N–O′) Examples of electron-lucent membrane structures. Single membrane bound (N and N’) and double membrane bound, typical of autophagosomes (O and O’). (P) Number of individual electron-lucent compartments (means: WT, 1.4; mtm RNAi cell, 6.8). Proportion of single (75 and 78%) and double (25 and 22%) membrane-bound electron-lucent structures remained unaffected. Error bars indicate SEM.